Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection

Transplantation

Volumn 89, Issue 2, 2010, Pages 222-226

  Wallia, Amisha ^a   Parikh, Neehar D ^a   Molitch, Mark E ^a   Mahler, Eileen ^a   Tian, Lu ^a   Huang, Jie Jenny ^a   Levitsky, Josh ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Hyperglycemia; Liver transplantation; Rejection

Indexed keywords

CYCLOSPORIN; GLUCOSE; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS;

ADULT; AGE; AGED; ARTICLE; ARTIFICIAL VENTILATION; CONFIDENCE INTERVAL; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GRAFT SURVIVAL; HIGH RISK PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERIOPERATIVE PERIOD; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; BLOOD GLUCOSE; FEMALE; GRAFT REJECTION; HUMANS; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREDNISONE; PREOPERATIVE CARE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TACROLIMUS; TREATMENT OUTCOME;

EID: 76649111394     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181c3c2ff     Document Type: Article

References (20)

1. Baird T, Parsons M, Phanh T, et al. Persistent post-stroke hyperglyce-mia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003; 34: 2208.
2. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systemic review. Lancet 2000; 355: 773.
3. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes, undergoing coronary bypass grafting. J Thorac Cardiovasc Surg 2003; 125: 1007.
4. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359.
5. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449.
6. Treggiari MM, Karir V, Yanez ND, et al. Intensive insulin therapy and mortality in critically ill patients. Crit Care 2008; 12: R29.
7. Thomas MC, Mathew TH, Russ GR, et al. Early peri-operative glycemic control and renal allograft rejection in patients without diabetes. BMC Nephrol 2000; 1: 1.
8. Tutone VK, Mark PB, Revanur V, et al. Random blood glucose measurements and survival in non-diabetic renal transplant recipients. Transplant Proc 2004; 36: 3006.
9. Delgado-Borrego A, Liu YS, Jordan SH, et al. Prospective study of liver transplant recipients with HCV infection: Evidence for a causal relationship between HCV and insulin resistance. Liver Transpl 2008; 14: 193.
10. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997; 25: 658.
11. Thomas MC, Mathew TH, Russ GR, et al. Early peri-operative glycemic control and allograft rejection in patients with diabetes mellitus: A pilot study. Transplantation 2001; 72: 1321.
12. Ganji MR, Charkhchian M, Hakemi M, et al. Association of hypergly-cemia on allograft function in the early period after renal transplantation. Transplantation Proc 2007; 39: 852.
13. John PR, Thulovath PJ. Outcome of liver transplantation in patients with diabetes mellitus: A case-control study. Hepatology 2001; 34: 889.
14. Ammori JB, Sigakis M, Englesbe MJ, et al. Effect of intraoperative hy-perglycemia during liver transplantation. J Surg Res 2007; 140: 227.
15. Hsaiky LM, Bajjoka IE, Patel D, et al. Postoperative use of intense insulin therapy in liver transplant recipients [abstract]. Am J Transplant 2008; 8(S2): 307.
16. Charlton M, Seaberg E. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: Results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Liver Transpl Surg 1999; 5(4 suppl 1): S107.
17. Ceriello A. Oxidative stress and diabetes-associated complications. En-docr Pract 2006; 12(suppl 1): 60.
18. Steinhoff G, Behrend M, Haverich A. Signs of endothelial inflammation in human heart allografts. Eur Heart J 1991; 12(suppl D): 141.
19. Melter M, McMahon G, Fang J, et al. Current understanding of che-mokine involvement in allograft transplantation. Pediatr Transplant 1999; 3: 10.
20. Shaked A, Ghobrial RM, Merion RM, et al; A2ALL Study Group. Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation.Am JTrans-plant 2009; 9: 301.